Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. senior Avg
|
New words:
accumulated, acute, adapt, addressing, adjunctive, affirmative, Aliz, analytical, antibody, anticompetitive, asparaginaseErwinia, Asparec, aspect, austerity, avoid, bear, Big, bioequivalence, biosimilar, BLA, black, body, BPCIA, bribery, British, broadly, capped, capromab, caption, casualty, cessation, cheaper, chemotherapy, Citizen, clause, Coast, coli, complementary, component, composed, condemnation, contractor, core, Corrupt, cure, declaratory, dedicated, denominated, deploy, deteriorating, disadvantage, disaster, dismissed, distract, dosing, doubtful, economy, employed, environment, Erwinase, essential, EU, Eurozone, evolving, exceeding, expedited, factor, fashion, FCP, FCPA, flexibility, floor, footprint, formal, formatting, fourteen, fourth, FSS, FTC, function, functional, GBP, graft, grown, guarantor, Guard, halted, headquartered, heard, heavily, hedging, host, HPA, hypersensitivity, improperly, impurity, incidence, infrastructure, inolimomab, insert, instability, internationally, intolerant, IRB, Kingdom, labor, lending, leukemia, Leukotac, Lexidronam, LIBOR, lymphoblastic, mandatory, maturity, medicinal, minimize, misleading, misstated, monoclonal, month, morphine, movement, objective, orin, outweigh, overcharge, pegylated, penalized, pendetide, pH, pharmacovigilance, population, Pound, poverty, prematurely, prepay, prevailing, prime, proceed, profile, prompt, ProstaScint, PSUR, purpose, Quadramet, radiopharmaceutical, recognizable, recombinantErwinia, referencing, refinance, refund, reinvestment, repay, repricing, requirein, rescind, restructuring, retrospective, revoked, routinely, samarium, scheme, scrutinize, Sm, sought, sovereign, sponsor, stability, Sterling, strain, struck, sublease, survey, swing, therapy, thirty, threshold, timeframe, TMA, toE, translate, translated, translation, truthful, underway, unobservable, unvested, VA, VHCA, vital, vitro, vitrobioequivalence, vivo, weakening, withdrawn
Removed:
arrangement, asserted, BB, beneficial, children, collected, commencing, commercialized, committed, compromise, converting, correct, detention, expire, fundamental, harmful, imposed, judicially, lowering, newer, observation, open, permission, preferable, qualification, restricting, senior, smoothly, studying, submitting, waiver
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.2 Lease
- 10.3 JAZZ Pharmaceuticals PLC 2012 Executive Officer Compensation Arrangements
- 10.4 Employment Agreement
- 10.5 Noncompetition Agreement
- 10.6 Amendment to Employment Agreement
- 10.7 Form of Stock Option Grant Notice and Form of Option Agreement (U.s.)
- 10.8 Form of Stock Option Grant Notice and Form of Option Agreement (Ireland)
- 10.9 Form of Restricted Stock Unit Grant Notice
- 10.10 Form of Restricted Stock Unit Grant Notice
- 31.1 Certification of CEO Pursuant to Rules 13A-14(A) and 15D-14(A)
- 31.2 Certification of CFO Pursuant to Rules 13A-14(A) and 15D-14(A)
- 32.1 Certifications of CEO and CFO Pursuant to 18 U.s.c. Section 1350
Related press release
JAZZ similar filings
Filing view
External links
Exhibit 10.3
2012 Executive Officer Compensation Arrangements
Executive Officer | Base Salary Rate(1) | Target Bonus as % of Annual Base Salary Rate | ||||
Bruce C. Cozadd Chairman and Chief Executive Officer | $ | 750,000 | 100 | |||
Kathryn E. Falberg Executive Vice President and Chief Financial Officer | $ | 460,000 | 50 | |||
Russell J. Cox Executive Vice President and Chief Commercial Officer | $ | 390,000 | 50 | |||
Suzanne Sawochka Hooper(2) Executive Vice President and General Counsel | $ | 465,000 | 50 | |||
Fintan Keegan(3) Executive Vice President, Technical Operations | € | 265,000 | 50 | |||
Jeffrey K. Tobias, M.D. Executive Vice President, Research and Development and Chief Medical Officer | $ | 425,000 | 50 | |||
Karen J. Wilson Vice President, Finance and Principal Accounting Officer | $ | 266,500 | 20-35 |
(1) | Base salary rate beginning on March 1, 2012. |
(2) | Ms. Hooper assumed her position effective on March 12, 2012. |
(3) | Mr. Keegan assumed his position effective on August 1, 2012. |